These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 6567464)
1. Disparity between timed-kill and checkerboard methods for determination of in vitro bactericidal interactions of vancomycin plus rifampin versus methicillin-susceptible and -resistant Staphylococcus aureus. Bayer AS; Morrison JO Antimicrob Agents Chemother; 1984 Aug; 26(2):220-3. PubMed ID: 6567464 [TBL] [Abstract][Full Text] [Related]
2. Novobiocin and rifampicin in combination against methicillin-resistant Staphylococcus aureus: an in-vitro comparison with vancomycin plus rifampicin. Walsh TJ; Auger F; Tatem BA; Hansen SL; Standiford HC J Antimicrob Chemother; 1986 Jan; 17(1):75-82. PubMed ID: 3633267 [TBL] [Abstract][Full Text] [Related]
3. Efficacy of vancomycin plus rifampin in experimental aortic-valve endocarditis due to methicillin-resistant Staphylococcus aureus: in vitro-in vivo correlations. Bayer AS; Lam K J Infect Dis; 1985 Jan; 151(1):157-65. PubMed ID: 3965588 [TBL] [Abstract][Full Text] [Related]
4. In-vitro effects of vancomycin, rifampicin, and fusidic acid, alone and in combination, against methicillin-resistant Staphylococcus aureus. Foldes M; Munro R; Sorrell TC; Shanker S; Toohey M J Antimicrob Chemother; 1983 Jan; 11(1):21-6. PubMed ID: 6826485 [TBL] [Abstract][Full Text] [Related]
5. In-vitro effects of vancomycin and rifampicin, alone and in combination, against methicillin-sensitive and methicillin-resistant staphylococci. Varaldo PE; Debbia E; Schito GC J Antimicrob Chemother; 1984 Dec; 14 Suppl D():35-41. PubMed ID: 6569872 [TBL] [Abstract][Full Text] [Related]
6. Synergy of combinations of vancomycin, gentamicin, and rifampin against methicillin-resistant, coagulase-negative staphylococci. Lowy FD; Chang DS; Lash PR Antimicrob Agents Chemother; 1983 Jun; 23(6):932-4. PubMed ID: 6555016 [TBL] [Abstract][Full Text] [Related]
7. Treatment of infections due to methicillin-resistant Staphylococcus aureus. Watanakunakorn C Ann Intern Med; 1982 Sep; 97(3):376-8. PubMed ID: 7114635 [TBL] [Abstract][Full Text] [Related]
8. Interaction between vancomycin and rifampin against Staphylococcus aureus. Watanakunakorn C; Guerriero JC Antimicrob Agents Chemother; 1981 Jun; 19(6):1089-91. PubMed ID: 7271276 [TBL] [Abstract][Full Text] [Related]
9. Susceptibility and synergy studies of methicillin-resistant Staphylococcus epidermidis. Ein ME; Smith NJ; Aruffo JF; Heerema MS; Bradshaw MW; Williams TW Antimicrob Agents Chemother; 1979 Nov; 16(5):655-9. PubMed ID: 260880 [TBL] [Abstract][Full Text] [Related]
10. Serum bactericidal activity of rifampin in combination with other antimicrobial agents against Staphylococcus aureus. Hackbarth CJ; Chambers HF; Sande MA Antimicrob Agents Chemother; 1986 Apr; 29(4):611-3. PubMed ID: 3707110 [TBL] [Abstract][Full Text] [Related]
11. Synergism between vancomycin and gentamicin or tobramycin for methicillin-susceptible and methicillin-resistant Staphylococcus aureus strains. Watanakunakorn C; Tisone JC Antimicrob Agents Chemother; 1982 Nov; 22(5):903-5. PubMed ID: 6924825 [TBL] [Abstract][Full Text] [Related]
12. In vitro activities of rifapentine and rifampin, alone and in combination with six other antibiotics, against methicillin-susceptible and methicillin-resistant staphylococci of different species. Varaldo PE; Debbia E; Schito GC Antimicrob Agents Chemother; 1985 Apr; 27(4):615-8. PubMed ID: 3847272 [TBL] [Abstract][Full Text] [Related]
13. In vitro activity of rifampin alone and in combination with nafcillin and Vancomycin against pathogenic strains of Staphylococcus aureus. Tuazon CU; Lin MY; Sheagren JN Antimicrob Agents Chemother; 1978 May; 13(5):759-61. PubMed ID: 666300 [TBL] [Abstract][Full Text] [Related]
14. Analysis of 42 cases of septicemia caused by an epidemic strain of methicillin-resistant Staphylococcus aureus: evidence of resistance to vancomycin. Burnie J; Matthews R; Jiman-Fatami A; Gottardello P; Hodgetts S; D'arcy S Clin Infect Dis; 2000 Sep; 31(3):684-9. PubMed ID: 11017816 [TBL] [Abstract][Full Text] [Related]
15. Differences in ability of cell-wall antibiotics to suppress emergence of rifampicin resistance in Staphylococcus aureus. Eng RH; Smith SM; Buccini FJ; Cherubin CE J Antimicrob Chemother; 1985 Feb; 15(2):201-7. PubMed ID: 3845078 [TBL] [Abstract][Full Text] [Related]
16. In vitro evaluation of clindamycin in combination with oxacillin, rifampin, or vancomycin against Staphylococcus aureus. Ho JL; Klempner MS Diagn Microbiol Infect Dis; 1986 Feb; 4(2):133-8. PubMed ID: 3956136 [TBL] [Abstract][Full Text] [Related]
17. Synergy study of vancomycin or teicoplanin plus gentamicin against enterococci, Staphylococcus aureus and coagulase-negative staphylococci by time-kill method. Thamlikitkul V J Med Assoc Thai; 1991 Dec; 74(12):669-74. PubMed ID: 1839906 [TBL] [Abstract][Full Text] [Related]
19. In vitro activities of nisin alone or in combination with vancomycin and ciprofloxacin against methicillin-resistant and methicillin-susceptible Staphylococcus aureus strains. Dosler S; Gerceker AA Chemotherapy; 2011; 57(6):511-6. PubMed ID: 22302084 [TBL] [Abstract][Full Text] [Related]
20. In vitro activity of rifampin in combination with oxacillin against Staphylococcus aureus. Maduri Traczewski M; Goldmann DA; Murphy P Antimicrob Agents Chemother; 1983 Apr; 23(4):571-6. PubMed ID: 6859835 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]